Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Androgen priming (drug) — also listed as: low dose hCG and aromatase inhibitor priming

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Lan N Vuong
  Ho Chi Minh City, Vietnam
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• combined oral contaraceptive pills (drug) — also listed as: Gynera
• recombinant FSH (drug)
• Urinaru gonadotropin (drug)
• GnRH antagonist (drug) — also listed as: Cetrotide
• Human chorionic gonadotropin (drug)
• GnRH agonist (drug) — also listed as: triptorelin
• Ovum pick up (procedure)
• Embryo transfer (procedure)
• natural Progesterone (drug) — also listed as: Prontogest

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Kasr Alainy medical school
  Cairo, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• highly purified human chorionic gonadotropin (drug) — also listed as: CHORAPUR, BREVACTID
• recombinant human chorionic gonadotropin (drug) — also listed as: OVIDREL, OVITRELLE

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Instituto Ideia Fértil de Saúde Reproductive (there may be other sites in this country)
  São Paulo, Brazil
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• HCG (drug)
• Lupron Trigger (drug)
• Dual Trigger (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Weill Cornell Medical College- Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine
  New York, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Fractional CO2 Laser Treatment (device) — also listed as: Fractional microablative CO2 laser system
• Sham Laser Treatment (device) — also listed as: Fractional microablative CO2 laser system

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Wake Forest Baptist Health
  Winston-Salem, North Carolina, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Self-assessment: MLPT (behavioral)
• Self-assessment: LSPT (behavioral)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Stanford Health Care
  Stanford, California, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Vaginal unprotected intercourse (behavioral)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• No hormone (other)
• hCG (other)
• GnRH a (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Hôpital Jean Verdier
  Bondy, France
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• BF4 (drug) — also listed as: Tetrafluoroborate, TFB

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Mayo Clinic in Rochester
  Rochester, Minnesota, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Dexamethasone (drug) — also listed as: recombinant human chorionic gonadotropin (r-hCG)
• recombinant human chorionic gonadotropin (r-hCG) (drug) — also listed as: Ovidrel

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• UCSD School of Medicine
  La Jolla, California, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• CAPA-IVM (drug)
• Standard-IVM (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• My Duc Hospital
  Ho Chi Minh City, Vietnam
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• hCG (drug) — also listed as: Pregnyl

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Open myomectomy (procedure)
• Gonadotropins (drug) — also listed as: Controlled Ovarian stimulation
• Human chorionic gonadotropin (drug) — also listed as: Ovulation triggering
• Ovum pick up (procedure)
• Embryo transfer (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Kasr Alainy medical school
  Cairo, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Collecting cervical liquid and sera samples (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Ege University, Medicine Faculty, Department of Obstetrics and Gynecology
  Izmir, Turkey (Türkiye)
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• DEVIT-3 (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Murat Özekinci
  Antalya, Turkey (Türkiye)
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Recombinant Human Chorionic Gonadotrophin (drug) — also listed as: Ovitrelle
• human chorionic gonadotrophin + gonadotrophin releasing hormone agonist (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Ahmed Abbas
  Assiut, Cairo Governorate, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Menopur (drug) — also listed as: gonadotropin
• Synarel (drug) — also listed as: GnRH agonist
• HCG trigger (drug) — also listed as: HCG
• Clomiphene citrate (drug) — also listed as: Clomid
• Letrozole (drug) — also listed as: Femara

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• New Hope Fertility Center
  New York, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Stem cell transplant x 1 or x 2 (procedure) — also listed as: In the initial 4 cycles of therapy, pts will receive oral lenalidomide at the, starting dose of 25mg on days 1-21 every 28 days (1 cycle) with dose, adjustments for creatinine clearance (CRCL) & dose reductions for toxicity., Pts will receive low-dose oral dexamethasone at 40mg weekly on days 1, 8, 15 &, 22 of each 28-day cycle with dose reductions as below for toxicity (the weekly, dose could be split over 2 days in the week i.e. 20mg on days 1, 4, 8, 11, 15,, 18, 22, & 25 for better tolerance). For SCT, pts are adm to hosp. High-dose, melphalan is admin in a single dose on day -2 or split dose on days -3 & -2,, through a cvc. Melphalan doseadjustments are made for age & CRCL,. Pts with, CRCL,> 51ml/min receive melphalan at 200mg/m2. Pts with CRCL < 51ml/min, (to be evaluated within 2 weeks of SCT) will receive 140mg/m2. Pts > 70 years, old receive 140mg/m2 also. Each SCT in a tandem SCT is a clinically discrete, event & these rules of dose adjustment apply to each SCT. It is possible,, that pts will get different doses of melphalan in tandem SCT
• lenalidomide and dexamethasone (drug) — also listed as: In the initial 4 cycles of therapy, pts will receive oral lenalidomide at the, starting dose of 25mg on days 1-21 every 28 days (one cycle) with dose, adjustments for creatinine clearance and dose reductions. Pts will receive, low-dose oral dexamethasone at 40mg weekly on days 1, 8, 15 & 22 of each, 28-day cycle with dose reductions (the weekly dose could be split over 2 days, in the week i.e. 20mg on days 1, 4, 8, 11, 15, 18, 22, & 25 for better, tolerance). For continued Ld, pts will resume Ld at the last dose tolerated, during the initial 4 cycles, with prophylactics & dose reductions as indicated., Lenalidomide will be continued until progression of disease, if as tolerated., Low-dose dexamethasone will be continued for 1 year (from the start of initial, treatment), as tolerated. Dose adjustments will follow guidelines. Pts will, be seen every 3 months by their physician & their disease will be reassessed., Pts will also have a CBC & pregnancy test performed monthly.

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Memoral Sloan Kettering Cancer Center
  Basking Ridge, New Jersey, United States
  Site recruitment: Not reported
• Memorial Sloan-Kettering Cancer Center @ Suffolk
  Commack, New York, United States
  Site recruitment: Not reported
• Memorial Sloan Kettering West Harrison
  Harrison, New York, United States
  Site recruitment: Not reported
• Memorial Sloan Kettering Cancer Center
  New York, New York, United States
  Site recruitment: Not reported
• Memorial Sloan Kettering at Mercy Medical Center
  Rockville Centre, New York, United States
  Site recruitment: Not reported
• Memoral Sloan Kettering Cancer Center at Phelps
  Sleepy Hollow, New York, United States
  Site recruitment: Not reported
• Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center
  Sleepy Hollow, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• natural cycle (other) — also listed as: natural LH surge
• modified natural cycle (other) — also listed as: recombinant hcg
• embryo transfer (other) — also listed as: frozen embryo transfer

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Acibadem MAA University Atakent Hospital
  Istanbul, Turkey (Türkiye)
  Site recruitment: Not reported